Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
DUSP4 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 19.70 | Evidence | |||||
DUSP4 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 7.18 | Evidence | O | ||||
DUSP4 | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 4.65 | Evidence | |||||
DUSP4 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 3.84 | Evidence | O | ||||
DUSP4 | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 3.69 | Evidence | |||||
DUSP4 | IRS1 | IRS1: Insulin receptor substrate 1 | 3.68 | Evidence | |||||
DUSP4 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 3.31 | Evidence | |||||
DUSP4 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 3.31 | Evidence | |||||
DUSP4 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 3.18 | Evidence | |||||
DUSP4 | MKNK2 | MKNK2, GPRK7, MNK2: MAP kinase-interacting serine/threonine-protein kinase 2 | 3.18 | Evidence | |||||
DUSP4 | MAPKAPK5 | N/A | 3.18 | Evidence | |||||
DUSP4 | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 2.43 | Evidence | |||||
DUSP4 | DYRK1B | DYRK1B, MIRK: Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 2.43 | Evidence | |||||
DUSP4 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 2.17 | Evidence | |||||
DUSP4 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 2.13 | Evidence | |||||
DUSP4 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 2.00 | Evidence | |||||
DUSP4 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 1.94 | Evidence | |||||
DUSP4 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 1.94 | Evidence | |||||
DUSP4 | STAT3 | 1.91 | Evidence | ||||||
DUSP4 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 1.87 | Evidence | |||||
DUSP4 | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 1.76 | Evidence | |||||
DUSP4 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 1.71 | Evidence | |||||
DUSP4 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 1.71 | Evidence | |||||
DUSP4 | SOS1 | SOS1: Son of sevenless homolog 1 | 1.62 | Evidence | |||||
DUSP4 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 1.62 | Evidence | |||||
DUSP4 | RPS6KB1 | N/A | 1.62 | Evidence | |||||
DUSP4 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 1.62 | Evidence | |||||
DUSP4 | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 1.59 | Evidence | |||||
DUSP4 | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 1.47 | Evidence | |||||
DUSP4 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 1.43 | Evidence | |||||
DUSP4 | LIFR | LIFR: Leukemia inhibitory factor receptor precursor | 1.30 | Evidence | |||||
DUSP4 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 1.25 | Evidence | |||||
DUSP4 | MAPK7 | MAPK7, ERK4, ERK5, PRKM7: Mitogen-activated protein kinase 7 | 1.18 | Evidence | |||||
DUSP4 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 1.12 | Evidence | |||||
DUSP4 | VAV1 | VAV1, VAV: Proto-oncogene vav | 1.12 | Evidence | |||||
DUSP4 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 1.10 | Evidence | |||||
DUSP4 | CLK4 | CLK4: Dual specificity protein kinase CLK4 | 1.10 | Evidence | |||||
DUSP4 | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 1.05 | Evidence |